Results March 2021
MAPFRE’s consolidated revenue in the first quarter of 2021 amounted to 7.3 billion euros, equivalent to a 0.4 percent decrease, and the attributable result stood at 173 million euros, which represents a 36.7 percent increase with respect to the previous year.
Revenue March 2021
Premiums March 2021
Non-Life premiums went down 2.6 percent, marked primarily by lower issuing in the Auto line, which fell 10.5 percent, primarily as a result of lower issuing in the United States, Italy, Turkey and Mexico. At constant exchange rates, Non-Life premiums would have grown 3.5%. It is important to point out the growth in the General P&C and Health businesses, which went up 6.6 and 4.0 percent in the quarter, respectively, thanks to positive development in Mexico, Spain, Colombia, and Brazil in General P&C, and in Spain and Mexico in Health & Accident.
By Non-Life business type, General P&C is the most important line, with over 1.6 billion euros in premiums. Auto holds second place, with almost 1.4 billion euros. Health and Accident is in third place with 907 million euros.
Life insurance premiums fell 6.2 percent, whereas at constant exchange rates they would have grown 1.7%. Of these, Life-Protection fell 15.1 percent, primarily from the currency effect in Brazil. Life-Savings premiums fell 8.3 percent, primarily from the fall in issuing in Mexico, Panama and Spain, in a complicated economic environment for the sale of these products.
Combined ratio March 2021
Net result March 2021
Balance sheet to March 2021
Total assets reached almost 70.0 billion euros at March 2021 and grew 1.2 percent compared to the close of the previous year.
The Group’s shareholders’ equity has been primarily impacted by a decrease in net unrealized gains on the available for sale portfolio, as a result of the increase in interest rates in the first quarter of the year.
Assets Under Management
The Solvency II ratio for MAPFRE Group stood at 192.9 percent with provisional figures at December 2020, compared to 186.8 percent at the close of December 2019, including transitional measures. These figures already reflect the impact of the application of Spanish Life business internal model for longevity risk, approved by local regulator April 2021, which imply a 6 p.p. uplift in the Solvency II ratio. Eligible Own Funds reached 8.9 billion euros in the same period.
The ratio maintained great solidity and stability, backed by high levels of diversification and strict investment and ALM policies.
- High quality capital base: 86% of eligible own funds are Tier 1.
- “Fully loaded” Solvency II ratio: 178.4% (excluding impact of transitional measures on technical provisions and equity).
Strategic Plan 2019-2021
Excellence in technical and operational management
Culture and talent
MAPFRE will sell SANTANDER products in the insurer’s 3,000 points of sale
Iberdrola and MAPFRE join forces in a strategic alliance to invest in renewable energy in Spain
MAPFRE holds its first Management Insights Day
MAPFRE holds its Annual General Meeting
MAPFRE holds its second virtual meeting with shareholders
MAPFRE launches the Unit Linked Colectivo Compromiso
S&P recognizes MAPFRE as a leader in sustainability
MAPFRE included in 2021 Bloomberg Gender-Equality Index
MAPFRE raises its stake in Abante to 20 percent
MAPFRE and Abante raise 300 million for its infrastructure fund on the back of strong investor interest
MAPFRE launches Programa Horizonte Inversión, an actively managed Unit Linked savings insurance product
MAPFRE, number seven in the ranking of most responsible companies and best corporate governance in Spain
Dividends and Shareholders
MAPFRE continues creating value for its shareholders
The Annual General Meeting held on March 12, 2021, agreed to pay a final dividend of 0.075 euros gross per share. This final dividend will be paid on May 24, 2021.
As such, along with the interim dividend paid this past December of 0.05 euros gross per share, the total dividend against results reaches 0.125 euros gross per share, which implies a payout ratio of 73.1 percent.